Loading, please wait....jpg)
.jpg)
The Premier Pharmacy Practice Forum webinar will feature one 60-minute Pharmacy Practice presentation. We are pleased to provide knowledge-based ACPE-accredited Continuing Education (CE) credits to pharmacists and pharmacy technicians for the Pharmacy Practice Presentations during our bi-monthly webinar meetings.
Noon – 1:00 PM EDT: Pharmacy Considerations for the Optimal Utilization of T-cell Engaging Bispecific Antibodies for Hematologic MalignanciesSpeaker: Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, Clinical Oncology Pharmacy Manager, Pharmacy Services - Levine Cancer Institute, Atrium Health, Charlotte, NC
ACPE Universal Program ID# 0122-0000-24-007-L01-P/T 1.0 Contact Hour [0.1 CEU]
Date: May 1, 2024 12:00 PM - 01:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on May 01, 2024 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Support/Credits
Premier, Inc. has received no outside support for the administration of this program.
Registration closes on May 01, 2024
at 12:10 PM
Registration closes on May 01, 2024
at 12:10 PM
Registration Closed
Registration Closed
Objectives
- Review the pharmacology and indications of recently approved T-cell engaging bispecific antibodies for the treatment of hematologic malignancies
- Evaluate efficacy data supporting the approval of bispecific antibodies for multiple myeloma and lymphomas
- Describe supportive care strategies to prevent and manage adverse events associated with bispecific antibodies
- Define best practices for pharmacies to overcome administration and operational challenges associated with bispecific antibodies
Speaker(s)/Author(s)
|
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP
|
Activity Number
0122-0000-24-007-L01-P/T
Date:
05/01/24
Time:
12:00 PM - 01:00 PM
CE Hours
1.00
Registration Closed